Study Title: Characterization Of The Cytotoxic Effects Of The Combination Of Cisplatin And Flavanol (-)-Epicatechin On Human Lung Cancer Cell Line A549. An Isobolographic Approach
Citation: Varela-Castillo et al., 2018 · Experimental Oncology
What the Study Found: The combination of cisplatin and (−)-epicatechin showed synergistic cytotoxic effects on human lung cancer A549 cells. Isobolographic analysis confirmed greater-than-additive cell death compared with either compound alone. The flavanol enhanced cisplatin’s anticancer activity without increasing toxicity to non-cancer cells in the model.
What this means in real life: Cancer cells often rely on altered mitochondrial metabolism to survive and resist chemotherapy. This study demonstrates that (−)-epicatechin can amplify cisplatin’s ability to disrupt energy production and trigger cell death in lung cancer cells. Mitochondrial support may therefore play a complementary role in helping conventional therapies work more effectively while protecting healthy cellular energy balance.
Contenu associé
- Curious how mitochondrial health intersects with cancer biology and recovery? → Cancer, Cellular Energy, and Mitochondria: Understanding the Biology Beneath the Surface
- Want to understand mitochondrial health in cancer recovery? → Mitochondrial Health in Cancer Recovery: Why Cellular Energy Matters After Treatment
- Looking for ways to support mitochondrial function daily? → How to Repair and Maintain Mitochondrial Health Naturally